...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: you won’t see anyone buying this

The best I can make it from financials/MD&A:

Balance, April 30,    2021, 135,302,493
Balance, April 30,    2022, 136,514,414 (fully diluted 150,053,009)
Balance, April 30,    2023, 148,499,462 (fully diluted 175,441,194)
Balance, Sept 27,    2023, 152,219,369  (fully diluted 184,683,974)

 

Koo

Share
New Message
Please login to post a reply